Sodium–glucose cotransporter 2 inhibitors: renal outcomes according to baseline albuminuria

Sodium–glucose co-transporter 2 inhibitors (SGLT2is) reduce albuminuria and hard renal outcomes (decline of renal function, renal replacement therapy and renal death) in patients with/without type 2 diabetes at high cardiovascular or renal risk. The question arises whether baseline albuminuria also...

Descripción completa

Detalles Bibliográficos
Autores principales: Delanaye, Pierre, Wissing, Karl Martin, Scheen, Andre J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
CKJ Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690058/
https://www.ncbi.nlm.nih.gov/pubmed/34950459
http://dx.doi.org/10.1093/ckj/sfab096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690058/
https://www.ncbi.nlm.nih.gov/pubmed/34950459
http://dx.doi.org/10.1093/ckj/sfab096

Ejemplares similares